G. Lärfars

发表

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

G. Birgegard, P. Näsman, A. Österborg, 2007, Leukemia.

G. Birgegard, P. Näsman, A. Österborg, 2008, Leukemia.

High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines

B. Wettermark, R. Malmström, L. Gustafsson, 2017, BMJ Open.

Initial symptoms in pulmonary embolism differ from those in pneumonia: a retrospective study during seven years

C. Jorup-Rönström, G. Lärfars, M. Söderberg, 2006, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Radiofrequency radiation exposure and other environmental concerns

S. Schulman, G. Lärfars, P. Lindmarker, 1999 .

Open Access ORIGINAL CLINICAL INVESTIGATION

S. Rosfors, G. Lärfars, L. Lapidus, 2010 .

A follow-up study of the fate of small asymptomatic deep venous thromboses

S. Rosfors, G. Lärfars, L. Lapidus, 2010, Thrombosis journal.

Prednisolone inhibits cytokine‐induced adhesive and cytotoxic interactions between endothelial cells and neutrophils in vitro

J. Bratt, G. Lärfars, M. Heimbürger, 2000, Clinical and experimental immunology.

Evaluation of Wells score and repeated D-dimer in diagnosing venous thromboembolism.

G. Lärfars, M. Söderberg, Maria Ljungqvist, 2008, European journal of internal medicine.

Asymptomatic deep venous thrombosis is associated with a low risk of post-thrombotic syndrome.

S. Rosfors, G. Lärfars, L. Lapidus, 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Obesity and thrombin-generation profiles in women with venous thromboembolism

J. Rosing, K. Bremme, M. Holmström, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18–65 years

J. Rosing, K. Bremme, M. Holmström, 2011, Thrombosis and Haemostasis.

Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.

G. Lärfars, I. Nilsson, M. Sten-Linder, 2011, The Journal of clinical endocrinology and metabolism.

A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism

S. Schulman, J. Boberg, G. Lärfars, 1996 .

Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months

O. Linder, S. Schulman, M. Holmström, 2006, Journal of thrombosis and haemostasis : JTH.

The use of D-dimer testing and Wells score in patients with high probability for acute pulmonary embolism.

L. Jorfeldt, G. Lärfars, M. Söderberg, 2009, Journal of evaluation in clinical practice.

Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes.

J. Palmblad, G. Lärfars, F. Lantoine, 1999, Blood.

Primary Upper Extremity Deep Venous Thrombosis and Comorbidity: A Population-Based Nationwide Study in Sweden

T. Arnhjort, G. Lärfars, H. Pettersson, 2017 .

Risk factors for recurrent venous thromboembolism in young and middle-aged women.

M. Holmström, G. Lärfars, H. Kieler, 2014, Thrombosis research.

The importance of the costoclavicular space in upper limb primary deep vein thrombosis, a study with magnetic resonance imaging (MRI) technique enhanced by a blood pool agent.

S. Rosfors, T. Arnhjort, G. Lärfars, 2014, European journal of internal medicine.

Hemodynamic and morphologic evaluation of sequelae of primary upper extremity deep venous thromboses treated with anticoagulation.

S. Rosfors, T. Arnhjort, G. Lärfars, 2006, Journal of vascular surgery.

A methodological study of computerized venous strain‐gauge plethysmography of the upper extremities

S. Rosfors, T. Arnhjort, G. Lärfars, 2005, Clinical physiology and functional imaging.

Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women.

G. Lärfars, J. Adami, H. Kieler, 2013, Thrombosis research.

F11 is associated with recurrent VTE in women

M. Bottai, J. Odeberg, A. Hamsten, 2016, Thrombosis and Haemostasis.

Deep venous thrombosis after surgery for Achilles tendon rupture: a provoked transient event with minor long‐term sequelae

S. Rosfors, G. Lärfars, L. Lapidus, 2011, Journal of thrombosis and haemostasis : JTH.

Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.

J. Odeberg, M. Holmström, G. Lärfars, 2016, Thrombosis research.

Post-Thrombotic Syndrome and Quality-of-Life after Venous Thromboembolism in Young and Middle-Aged Women

M. Holmström, G. Lärfars, H. Kieler, 2015 .

Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor.

G. Lärfars, J. Samuelsson, 1999, Leukemia research.

[New drug in atrial fibrillation--how does it function in regular health care?].

P. Hjemdahl, R. Malmström, M. Holmström, 2009, Lakartidningen.

Gamma Interferon Treatment of Patients with Chronic Granulomatous Disease Is Associated with Augmented Production of Nitric Oxide by Polymorphonuclear Neutrophils

J. Palmblad, G. Lärfars, G. Elinder, 1999, Clinical Diagnostic Laboratory Immunology.

Stimulus-dependent transduction mechanisms for nitric oxide release in human polymorphonuclear neutrophil leukocytes.

G. Lärfars, H. Gyllenhammar, 1998, The Journal of laboratory and clinical medicine.

Measurement of methemoglobin formation from oxyhemoglobin. A real-time, continuous assay of nitric oxide release by human polymorphonuclear leukocytes.

G. Lärfars, H. Gyllenhammar, Hans Gyllenhammar, 1995, Journal of immunological methods.

Risk factors for venous thromboembolism in pre-and postmenopausal women.

J. Odeberg, K. Hedenmalm, I. Persson, 2012, Thrombosis research.

Prolonged Thromboprophylaxis With Dalteparin After Surgical Treatment of Achilles Tendon Rupture: A Randomized, Placebo-Controlled Study

S. Rosfors, S. Ponzer, G. Lärfars, 2007, Journal of orthopaedic trauma.

Electrochemical detection of nitric oxide production in human polymorphonuclear neutrophil leukocytes.

G. Lärfars, F. Lantoine, M. Devynck, 1999, Scandinavian journal of clinical and laboratory investigation.

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

O. Linder, S. Schulman, J. Boberg, 1997, The New England journal of medicine.

Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae.

U Ludwigs, S. Rosfors, T. Arnhjort, 2007, European journal of internal medicine.

Oral cladribine for B‐cell chronic lymphocytic leukaemia: report of a phase II trial with a 3‐d, 3‐weekly schedule in untreated and pretreated patients, and a long‐term follow‐up of 126 previously untreated patients

E. Kimby, A. Delannoy, G. Juliusson, 2002, British journal of haematology.

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.

J. Palmblad, M. Björkholm, G. Birgegard, 2004, Haematologica.

TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders

J. Palmblad, M. Björkholm, G. Birgegard, 2008, International journal of medical sciences.

A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism

Olle Linder, K. Schulman, O. Linder, 1995 .

Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population

G. Lärfars, N. Juth, L. Sandman, 2021, Journal of Medical Ethics.

Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study

Olle Broström, T. Lindahl, G. Lärfars, 2010, BMC gastroenterology.

Long-term quality of life and postthrombotic syndrome in women after an episode of venous thromboembolism

M. Holmström, G. Lärfars, H. Kieler, 2018, Phlebology.

Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: A randomized placebo-controlled, double-blind study

S. Rosfors, S. Ponzer, G. Lärfars, 2007, Acta orthopaedica.

Letter of apology

G. Lärfars, H. Gyllenhammar, 1996 .

Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use

M. Ovesjö, G. Lärfars, M. Ågerstrand, 2020, European Journal of Clinical Pharmacology.

Non‐steroidal anti‐inflammatory drugs and venous thromboembolism in women

K. Hedenmalm, I. Persson, A. Sundström, 2013, Pharmacoepidemiology and drug safety.

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

G. Lärfars, B. Ljungberg, E. Loogna, 1995, The New England journal of medicine.